Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series
about
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)In vitro activities of 11 fluoroquinolones against 816 non-typhoidal strains of Salmonella enterica isolated from Finnish patients with special reference to reduced ciprofloxacin susceptibility.Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhiAntimicrobial susceptibility patterns of Salmonella enterica serotype typhi in eastern NepalMolecular basis of resistance displayed by highly ciprofloxacin-resistant Salmonella enterica serovar Typhi in BangladeshFirst detection of oqxAB in Salmonella spp. isolated from food.Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.Detection of plasmid-mediated KPC-producing Klebsiella pneumoniae in Ottawa, Canada: evidence of intrahospital transmissionThe trials of the returning traveler: ciprofloxacin failure in enteric fever.A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis.High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli.In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards.Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options.Laboratory-based surveillance of paratyphoid fever in the United States: travel and antimicrobial resistance.Bug on the back: vertebral osteomyelitis secondary to fluoroquinolone resistant Salmonella typhi in an immunocompetent patient.An all-inclusive vacation.Development of a real-time PCR assay for detection of gyrA mutations associated with reduced susceptibility to ciprofloxacin in Salmonella enterica serovar typhi and paratyphi A.Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal.Quinolone resistance of Salmonella enterica serovar Virchow isolates from humans and poultry in Israel: evidence for clonal expansionCefotaxime-ciprofloxacin combination therapy for nontyphoid Salmonella bacteremia and paravertebral abscess after failure of monotherapy.The analysis of GM (1, 1) grey model to predict the incidence trend of typhoid and paratyphoid fevers in Wuhan City, China
P2860
Q24241438-51521DFC-93D7-4D47-BBF2-F652AFDCBA0FQ24812949-BCD1BEA6-2656-4C74-8531-4A6AEC4360EAQ24814191-15F89511-6A18-4828-8F7D-9D589537725AQ34453931-9FC3BA70-E6E6-4870-9195-5E4AF181E224Q35073518-CC37F939-D0AC-4E7E-A59D-B0B642E2B31BQ36505499-6B8D98DD-2000-4C75-82BA-B9CD25B5344EQ36538683-12685659-9228-4E1D-8D33-4E6C849EF11FQ37214062-46A141CD-615A-4C22-8578-F568F2F6F683Q37400673-5249E27B-D6E7-44A8-8661-4B10B7F38754Q37506861-D8A60DF6-5BCC-44E8-86BC-8F0C40D7BDA4Q37742457-185EBA20-7ECE-4899-87BF-A1FC0E4F6AB2Q38023251-D3DA5AF0-EB45-41A2-999D-33FDBB221320Q39431565-BE886D3F-6719-4C7A-8BFE-3986C3B2144CQ40101350-F873A562-77B5-4418-8269-EBC46DB98EB3Q40128772-4F0DB393-0203-4997-B888-F4CA505365DFQ40445365-02D4F5B2-AD7A-4BAB-AA61-02228809A3D4Q40469531-8F3448C4-2AF2-41BC-9753-44B4DA86EF58Q40482248-70D5ADE9-711D-4457-A436-290D74EBC94DQ42413026-93243F54-A71C-44E5-95C9-57C97EAC0B18Q50075986-B0CFBBF7-BE1A-49A8-AD95-5E98CB08AEDBQ57929601-65B1DBFA-AE99-4167-81F2-7E937ED21F74
P2860
Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Suboptimal clinical response t ...... susceptibility: a case series
@ast
Suboptimal clinical response t ...... susceptibility: a case series
@en
Suboptimal clinical response t ...... susceptibility: a case series
@nl
type
label
Suboptimal clinical response t ...... susceptibility: a case series
@ast
Suboptimal clinical response t ...... susceptibility: a case series
@en
Suboptimal clinical response t ...... susceptibility: a case series
@nl
prefLabel
Suboptimal clinical response t ...... susceptibility: a case series
@ast
Suboptimal clinical response t ...... susceptibility: a case series
@en
Suboptimal clinical response t ...... susceptibility: a case series
@nl
P2093
P2860
P356
P1476
Suboptimal clinical response t ...... susceptibility: a case series
@en
P2093
Baldwin Toye
Christiane Guibord
Karam Ramotar
Marc Desjardins
Peter Jessamine
Robert Slinger
P2860
P2888
P356
10.1186/1471-2334-4-36
P407
P577
2004-09-20T00:00:00Z
P5875
P6179
1001542763